The Impact of CoronaVac Vaccination on 28-day Mortality Rate of Critically Ill Patients with COVID-19 in Türkiye.

Background: Vaccines against coronavirus disease-19 (COVID-19) have been effective in preventing symptomatic diseases, hospitalizations, and intensive care unit (ICU) admissions. However, data regarding the effectiveness of COVID-19 vaccines in reducing mortality among critically ill patients with COVID-19 remains unclear. Aims: To determine the vaccination status and investigate the impact of the COVID-19 vaccine on the 28-day mortality in critically ill patients with COVID-19. Study Design: Multicenter prospective observational clinical study. Methods: This study was conducted in 60 hospitals with ICUs managing critically ill patients with COVID-19. Patients aged ≥ 18 years with confirmed COVID-19 who were admitted to the ICU were included. The present study had two phases. The first phase was designed as a one-day point prevalence study, and demographic and clinical findings were evaluated. In the second phase, the 28-day mortality was evaluated. Results: As of August 11, 2021, 921 patients were enrolled in the study. The mean age of the patients was 65.42 ± 16.74 years, and 48.6% (n = 448) were female. Among the critically ill patients with COVID-19, 52.6% (n = 484) were unvaccinated, 7.7% (n = 71) were incompletely vaccinated, and 39.8% (n = 366) were fully vaccinated. A subgroup analysis of 817 patients who were unvaccinated (n = 484) or who had received two doses of the CoronaVac vaccine (n = 333) was performed. The 28-day mortality rate was 56.8% (n = 275) and 57.4% (n = 191) in the unvaccinated and two-dose CoronaVac groups, respectively. The 28-day mortality was associated with age, hypertension, the number of comorbidities, type of respiratory support, and APACHE II and sequential organ failure assessment scores (p < 0.05). The odds ratio for the 28-day mortality among those who had received two doses of CoronaVac was 0.591 (95% confidence interval: 0.413-0.848) (p = 0.004). Conclusion: Vaccination with at least two doses of CoronaVac within six months significantly decreased mortality in vaccinated patients than in unvaccinated patients.

Serum Procalcitonin Levels in Postoperative Monitoring of Diabetic Patients with Posterior Lumber Vertebral Stabilization Surgery: A Prospective Comparative Study.

OBJECTIVE: To compare the serum procalcitonin levels and other infection markers released in response to the inflammatory response that develops secondary to the operation in patients with or without type 2 diabetes mellitus who underwent spinal instrumentation. METHODS: Fifty patients, who belonged to the American Society of Anesthesiologist I-II, were between 18 and 65 years of age, and who had planned for posterior spinal instrumentation surgery were grouped into 2 as group I (n = 25) type 2 diabetic patients (group DM) and group II (n=25) non-diabetic patients (group non-DM). On the operation day, preoperatively (T0), 5 minutes after intraoperative instru- ment placement (T1), on postoperative 24th hour (T2), 48th hour (T3), 3rd day (T4), 5th day (T5), 7th day (T6), 10th day (T7), and 15th day (T8), serum samples were obtained from the patients for the evaluation of procalcitonin, C-reactive protein, erythrocyte sedimentation rate, and neutrophil values. RESULTS: Procalcitonin levels were higher in the diabetic patient group at all time points (P < .01); C-reactive protein levels were higher in T1, T2, and T5 in the diabetic patient group (P < .05). There was no difference in erythrocyte sedimentation rate or neutrophil counts between the groups (P > .05). When the alterations in procalcitonin levels were compared between diabetic and non-diabetic groups, in diabetic patients, there were significantly higher increases in the first 6 timelines (P <.05). CONCLUSION: In diabetic patients, the procalcitonin levels were significantly higher at all time points, predicting an augmented bacterial infection in those patients compared with the non-diabetic patients.

Approach to Perioperative Hypothermia by Anaesthesiology and Reanimation Specialist in Turkey: A Survey Investigation.

OBJECTIVE: The aim is to investigate the attitudes of anaesthesiologists working in Turkey on perioperative temperature monitoring. METHODS: The questionnaire comprised 25 questions. Data were obtained through the completion of the questionnaire by hand or via the web. RESULTS: Two hundred and four questionnaires were evaluated. Most physicians were working in government hospitals. We determined that 26% of physicians often use temperature monitoring and that physicians who works in university hospitals are significantly more common monitor the body temperature. There are different approachs on core temperature. The skin/axilla was the most preferred monitoring site; forced-air warming devices were the most common preferred heating systems. New-borns were the most commonly monitored group, and the Turkish Anaesthesiology and Reanimation Society guideline was the most commonly used reference. Physicians working in university or private hospitals were significantly more able to adjust the operating room temperature on demand. CONCLUSION: There are different applications to prevent perioperative hypothermia. Although physicians are aware of the effects of anaesthesia on hypothermia and the contribution of hypothermia to complications, this awareness was not enough for them to make temperature monitoring a routine practice. To make temperature monitoring a standard practice, we believe that more studies should be conducted and that this issue needs to be more frequently addressed in congresses, anaesthesia conferences and particularly in residency training clinics.

Effects of Nasal Septum Deviation and Septoplasty on Cardiac Arrhythmia Risk.

OBJECTIVE: Upper airway obstruction (UAO) can result in cardiac complications, including arrhythmias and sudden cardiac death. Nasal septum deviation (NSD) is a common cause of UAO. The aim of this study was to assess the risk of cardiac arrhythmias in patients with NSD. To assess this risk, we measured noninvasive indicators of atrial arrhythmia (P-wave dispersion [Pd]) and ventricular arrhythmia (corrected QT dispersion [QTcd]) and compared these values between NSD patients and healthy subjects. STUDY DESIGN: Prospective study. SETTINGS: Tertiary referral center. SUBJECTS AND METHODS: This study included 53 consecutive patients who had underwent septoplasty due to marked NSD. Electrocardiographic records were used to determine Pd and QTcd values preoperatively and 6 months postoperatively. Fifty-three consecutive age- and sex-matched subjects without any UAO were also examined as a control group. RESULTS: Preoperative Pd and QTcd values were significantly higher in NSD patients than in the control group (Pd: 57.40 ± 14.21 vs 34.11 ± 7.12 milliseconds, P < .001; QTcd: 81.77 ± 16.39 vs 50.25 ± 11.51 milliseconds, P < .001, respectively). In addition, Pd and QTcd values were significantly greater in preoperative NSD patients when compared with the same patients postoperatively (Pd: 57.40 ± 14.21 vs 36.32 ± 8.9 milliseconds, P = .013; QTcd: 81.77 ± 16.39 vs 55.76 ± 11.4 milliseconds, P = .012, respectively). CONCLUSION: In conclusion, NSD patients are at risk for both atrial and ventricular cardiac arrhythmias; however, septoplasty in these patients can relieve UAO and reduce the risk of arrhythmias.